EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CELUW: Celularity Inc WT

28 Nov 25 10:51
LAST:

0.0246

CHANGE:
 0.00		OPEN:
0.0247		HIGH:
0.0247		ASK:
0.0000		VOLUME:
400
CHG(%):
0.40		PREV:
0.0247		LOW:
0.0246		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
28 Nov 250.02470.02470.02460.02463.3K
26 Nov 250.01950.02470.01900.024722.7K
25 Nov 250.02740.02740.02730.0273400
24 Nov 250.02000.02740.01780.02732.3K
21 Nov 250.01750.02840.01740.02736.9K
20 Nov 250.02290.02840.01740.0174600
19 Nov 250.02640.02640.02640.0264100
18 Nov 250.02440.02840.02440.02832.9K
17 Nov 250.02220.02220.02220.0222100
14 Nov 250.01990.02190.01620.0199117.8K

PROFILE

Name:Celularity Inc WT
About:Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:170 Park Avenue, Florham Park, NJ, United States, 07932
Website:https://www.celularity.com
CIK:0001752828
ISIN:US1511901134
FIGI:BBG00PPX2Y16

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.036.5%
MA10:0.020.4%
MA20:0.021.7%
MA50:0.0327.6%
MA100:0.0463.8%
MA200:0.0586.2%
STO9:65.45
STO14:65.45
RSI14:50.34
WPR14:-33.95
MTM14:0.00
ROC14:0.18 
ATR:0.01 
Week High:0.0315.4%
Week Low:0.0241.4%
Month High:0.0315.4%
Month Low:0.0286.2%
Year High:0.752,953.3%
Year Low:0.01112.1%
Volatility:110.43